- Home
- CCM vs CGTX Comparison
CCM vs CGTX Comparison
Compare CCM & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- CGTX
- Stock Information
- Founded
- CCM 1997
- CGTX 2007
- Country
- CCM China
- CGTX United States
- Employees
- CCM N/A
- CGTX N/A
- Industry
- CCM Medical/Nursing Services
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- CGTX Health Care
- Exchange
- CCM Nasdaq
- CGTX Nasdaq
- Market Cap
- CCM 18.2M
- CGTX 20.5M
- IPO Year
- CCM 2009
- CGTX 2021
- Fundamental
- Price
- CCM $7.05
- CGTX $0.29
- Analyst Decision
- CCM
- CGTX Strong Buy
- Analyst Count
- CCM 0
- CGTX 5
- Target Price
- CCM N/A
- CGTX $5.63
- AVG Volume (30 Days)
- CCM 26.2K
- CGTX 2.2M
- Earning Date
- CCM 06-17-2025
- CGTX 05-07-2025
- Dividend Yield
- CCM N/A
- CGTX N/A
- EPS Growth
- CCM N/A
- CGTX N/A
- EPS
- CCM N/A
- CGTX N/A
- Revenue
- CCM $52,603,198.00
- CGTX N/A
- Revenue This Year
- CCM N/A
- CGTX N/A
- Revenue Next Year
- CCM N/A
- CGTX N/A
- P/E Ratio
- CCM N/A
- CGTX N/A
- Revenue Growth
- CCM N/A
- CGTX N/A
- 52 Week Low
- CCM $3.80
- CGTX $0.22
- 52 Week High
- CCM $26.70
- CGTX $2.54
- Technical
- Relative Strength Index (RSI)
- CCM 49.10
- CGTX 43.08
- Support Level
- CCM $6.70
- CGTX $0.24
- Resistance Level
- CCM $7.67
- CGTX $0.36
- Average True Range (ATR)
- CCM 0.58
- CGTX 0.04
- MACD
- CCM -0.19
- CGTX 0.00
- Stochastic Oscillator
- CCM 12.59
- CGTX 49.35
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.